As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results ...

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest ...

Medifast's strong quarterly performance, investments in growth strategies, and undervalued stock make it an attractive ...

Third Quarter 2024 Results Key Financial Results Revenue: US$140.2m (down 41% from 3Q 2023).

Fintel reports that on November 5, 2024, DA Davidson upgraded their outlook for Medifast (NYSE:MED) from Underperform to ...

DA Davidson analyst Linda Bolton Weiser upgraded Medifast (MED) to Neutral from Underperform with a price target of $17, up from $16.50. With ...

Medifast ( (MED) ) has released its Q3 earnings. Here is a breakdown of the information Medifast presented to its investors. Medifast (NYSE: ...

Medifast, Inc. (NYSE:MED) reported a significant EPS of $0.1029, outperforming the anticipated loss. The company’s revenue reached approximately $140.2 million, surpassing estimates and indicating ...

Greetings, and welcome to the Medifast Third Quarter 2024 Earnings Conference Call. At this time, all participants are on a listen-only mode. A brief question-and-answer session will follow the ...

BALTIMORE (AP) — BALTIMORE (AP) — Medifast Inc. (MED) on Monday reported profit of $1.1 million in its third quarter. On a per-share basis, the Baltimore-based company said it had profit of 10 ...